Compare Sana Biotechnology Inc (SANA) vs Ishares Msci Thailand Etf (THD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Ishares Msci Thailand Etf — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $1.03B), while Ishares Msci Thailand Etf trades at $74.77. The key difference: Ishares Msci Thailand Etf is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | THD | |
|---|---|---|
Market Cap | $1.03B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $5.92 | $75.06 |
52-Week Low | $2.68 | $57.86 |
Enterprise Value | $946.04M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $3.45, down 10.39% in the past 24 hours, reflecting bearish technical signals and negative profitability. The company reported a net loss of $244.17 million for 2025, with a price-to-book ratio of 6.68. Recent news includes investor conference presentations and a peer-reviewed publication in The New England Journal of Medicine highlighting clinical data.
Despite analyst consensus favoring a 'Buy' rating (81.82% of 11 analysts), the stock faces significant risks from negative cash flows, high losses, and potential fiduciary concerns. Upside hinges on successful clinical developments and improved financial performance, but current fundamentals suggest caution for investors.
THD trades at $75.06, up 2.28% with a bearish technical signal from moving averages. The stock shows neutral oscillator readings but faces selling pressure per ADX indicators. Recent news highlights THD's 38% annual returns driven by AI hardware exposure, though this creates vulnerability to profit-taking. Support levels cluster around $71-72 with resistance at $72-73.
Outlook remains cautious due to technical weakness and concentrated AI dependency. The dividend scheduled for June 2026 provides income support, but investors face rotation risks from Asian equities and Thailand's economic sensitivity to regional flows. Valuation metrics remain undisclosed in current data.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →
